1055880-14-2

Upstream product

• 104-63-2 N-Benzylethanolamine 
• 151982-51-3 4-bromo-2-fluorobenzoyl chloride 
• 1055880-13-1 N-benzyl-4-bromo-2-fluoro-N-(2-hydroxyethyl)benzamide 

Downstream Products

• 1055880-15-3 4-benzyl-8-bromo-2,3,4,5-tetrahydro-1,4-benzoxazepine 

Relevant academic research and scientific papers

Aminoheteroaryl benzamides as kinase inhibitors

The present invention provides a compound of Formula (I) or a salt thereof; and therapeutic uses of these compounds. The present invention further provides pharmaceutical compositions comprising these compounds, and compositions comprising these compounds with a therapeutic co-agent.

BENZOXAZEPINE DERIVATIVES AND USE THEREOF

Compounds represented by the general formula (I): wherein each symbol is as defined in the description [with the proviso that 9-chloro-7-(1,1-dimethylethyl)-2,3,4,5-tetrahydro-1,4-benz-oxazepine and N-[[(5S)-2-oxo-3-(2,3,4,5-tetrahydro-1,4-benz-oxazepin-7-yl)-5-oxazolidinyl]methyl]acetamide are excluded], salts of the same, and prodrugs thereof have selective activation effect on serotonin 5-HT2C receptor and are useful as preventive and therapeutic agents for lower urinary tract diseases, obesity, and/or pelvic organ prolapse.